← All indications
Mucositis
An INFLAMMATION of the MUCOSA with burning or tingling sensation. It is characterized by atrophy of the squamous EPITHELIUM, vascular damage, inflammatory infiltration, and ulceration. It usually occurs at the mucous lining of the MOUTH, the GASTROINTESTINAL TRACT or the airway due to chemical irritations, CHEMOTHERAPY, or radiation therapy (RADIOTHERAPY).
Drugs by status
Approved for this indication (3)
Phase 4 trials (14)
Phase 3 trials (41)
- sodium fluoride (18F)
- hydrocodone
- mercaptopurine
- aloe vera
- acetylcysteine
- ketamine
- sucralfate
- nelarabine
- oxycodone
- ibuprofen
- gabapentin
- imatinib
- l-glutamine
- naltrexone
- manuka honey
- leucovorin
- mupirocin
- vincristine
- pegaspargase
- acetaminophen
- lidocaine
- allogeneic hematopoietic stem cells
- cyclophosphamide
- daunorubicin
- tantum verde
- clonidine
- hydromorphone
- ulinastatin
- curcumin
- zinc dichloride
- +11 more
Phase 2 trials (47)
- simvastatin
- melatonin
- maltodextrin
- vitamin d3
- spirulina
- amifostine
- benzocaine
- atl-104
- beetroot juice
- brilacidin
- cetylpyridinium chloride
- doxycycline
- echinacea
- folic acid
- paclitaxel
- hydroxychloroquine
- Avasopasem
- naproxen
- propolis
- carboplatin
- levobupivacaine
- semaglutide
- stem cells
- everolimus
- taurine
- pantoprazole
- glucarpidase
- miconazole
- l-epigallocatechin
- bovine immunoglobin
- +17 more
Phase 1 trials (11)
Organizations
Organization Involved with Phase 4 Indications (21)
- Swedish Orphan Biovitrum
- Sun Pharmaceuticals
- Institute for Professional Education in Dentistry
- University of Roma La Sapienza
- Jiangmen Central Hospital
- Riyadh Colleges of Dentistry and Pharmacy
- Universitat Internacional de Catalunya
- University of Nebraska
- Tel Aviv University
- University of Copenhagen
- University of Naples Frederico II
- King Faisal Specialist Hospital
- Proed
- Sun Yat-Sen University
- Biovitrum AB
- University of Western Australia
- PharPoint Research, Inc.
- Shanxi Zhendong pharmaceutical Co. LTD.
- Danish University
- People's Liberation Army of China
- Midatech Pharma
Organization Involved with Phase 3 Indications (55)
- Abbott
- McNeil
- Amgen
- Novartis
- Angelini
- Biotec Pharmacon ASA
- Endo Pharmaceuticals
- Healios K.K.
- Colgate Palmolive
- Soligenix
- British Columbia Cancer Agency
- National Cancer Institute (NCI)
- Cairo University
- Centre Leon Berard
- University of London
- First People's Hospital of Foshan
- Guangzhou Medical University
- Hoosier Cancer Research Network
- McMaster University
- Medical College of Wisconsin
- Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre
- Radiation Therapy Oncology Group
- Southwest Oncology Group
- University of Miami
- University of Toronto
- Wayne State University
- University of Leipzig
- Mayo Clinic
- Comprehensive Support Project for Oncology Research
- Taichung Veterans General Hospital
- +25 more
Organization Involved with Phase 2 Indications (111)
- Alizyme
- Spectrum Pharmaceuticals
- RxKinetix
- CuraGen
- AstraZeneca
- MedImmune
- Pfizer
- Catalysis SL
- CONRAD
- Exsulin Corporation
- Indena S.p.A
- Izun Pharma Ltd
- Moberg Pharma AB
- Mucosal Therapeutics
- Mundipharma
- Valerio
- Oral Defense, LLC
- Piramal
- SciClone Pharmaceuticals
- Spherium Biomed
- Sponsor GmbH
- Access Pharmaceuticals, Inc.
- Daewoong Pharmaceutical Co. LTD.
- EpicentRx, Inc.
- Otsuka
- Sucampo
- National Institute of Dental and Craniofacial Research (NIDCR)
- Shahid Beheshti University of Medical Sciences
- Aarhus University
- University of Arizona
- +81 more
Organization Involved with Phase 1 Indications (14)
Organization Involved with Other Experimental Indications (27)
- Fresenius
- Bitop AG
- VSL Pharmaceuticals
- The Christie NHS Foundation Trust
- National Cancer Institute, Egypt
- University of Pennsylvania
- Ain Shams University
- Children's Cancer and Leukaemia Group
- New York University
- Northwell Health
- Rutgers University
- University of Medicine and Dentistry of New Jersey
- University of Milan
- Fujian Medical University
- Taipei Medical University
- Nasser Institute For Research and Treatment
- University of Minnesota
- The University of Hong Kong
- Sao Paulo State University
- Department of Veteran Affairs
- Dentaid
- Nutricia
- Government of Hong Kong
- University of Geneva
- Chulabhorn Hospital
- Federico Gomez Children's Hospital of Mexico
- National Institute of Pediatrics